Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACP1 | P24666 | 2/20 | 0.59 |
| ▸ | ABCG2 | Q9UNQ0 | 6/20 | 0.56 |
| ▸ | TSHR | P16473 | 4/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 4/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | PDE5A | O76074 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13877449 | 0.92 | ACP1 (0.51) | ACP1ABCG2TSHRMAPK1HSD17B10 | |
| SCHEMBL13877273 | 0.91 | ACP1 (0.50) | ACP1ABCG2TSHRMAPK1HSD17B10 | |
| SCHEMBL15213846 | 0.90 | ACP1 (0.50) | ACP1ABCG2TSHRMAPK1HSD17B10 | |
| SCHEMBL28613944 | 0.89 | CYP1A1 (0.56) | ACP1ABCG2TSHRMAPK1HSD17B10 | |
| SCHEMBL15371685 | 0.89 | ABCG2 (0.50) | ACP1ABCG2TSHRMAPK1HSD17B10 | |
| SCHEMBL26598439 | 0.89 | ABCG2 (0.53) | ACP1ABCG2TSHRMAPK1HSD17B10 | |
| SCHEMBL20068422 | 0.87 | ABCG2 (0.53) | ACP1ABCG2TSHRMAPK1HSD17B10 | |
| SCHEMBL21212971 | 0.87 | ACP1 (0.48) | ACP1ABCG2TSHRMAPK1HSD17B10 | |
| SCHEMBL21212969 | 0.87 | ACP1 (0.48) | ACP1ABCG2TSHRMAPK1HSD17B10 | |
| SCHEMBL16905625 | 0.87 | ACP1 (0.48) | ACP1ABCG2TSHRMAPK1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090091240-A1 | COMPOUND CONTAINING FUSED RING AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2009-04-09 | — | — | US | disclosed |
| US-20090091240-A1 | COMPOUND CONTAINING FUSED RING AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2009-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090091240-A1 | COMPOUND CONTAINING FUSED RING AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | INTS9, KCNN2, KCNH3 | ACP1 3070/4885ABCG2 922/4885TSHR 4522/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.